Product Data Sheet

CNJ-294

Catalog No. A70855

main product photo
CNJ-294 is a drug metabolite and an intermediate in the synthesis of Capmatinib. It plays a crucial role in understanding the metabolic pathways and pharmacokinetics of Capmatinib. Research applications of CNJ-294 include studies on drug metabolism, efficacy, and safety in the context of specific cancer therapies.
Chemical Information
Catalog NumA70855
M. Wt398.39
FormulaC22H15FN6O
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.1029713-99-2
Synonyms
SMILESO=C(C1=C(F)C=C(C2=NN3C(N=C2)=NC=C3CC4=CC5=CC=CN=C5C=C4)C=C1)N
Biological Activity
DescriptionCNJ-294 is a drug metabolite and an intermediate in the synthesis of Capmatinib. It plays a crucial role in understanding the metabolic pathways and pharmacokinetics of Capmatinib. Research applications of CNJ-294 include studies on drug metabolism, efficacy, and safety in the context of specific cancer therapies.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.